1. Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience. (September 2016) Authors: Bluthgen, M.V.; Boutros, C.; Fayard, F.; Remon, J.; Planchard, D.; Besse, B. Journal: Lung cancer Issue: Volume 99(2016) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy. Issue 3 (September 2015) Authors: Kossai, M.; Duchemann, B.; Boutros, C.; Caramella, C.; Hollebecque, A.; Angevin, E.; Gazzah, A.; Bahleda, R.; Ileana, E.; Massard, C.; Vielh, P.; Soria, J.C.; Besse, B. Journal: Lung cancer Issue: Volume 89:Issue 3(2015:Sep.) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. (February 2016) Authors: Michot, J.M.; Bigenwald, C.; Champiat, S.; Collins, M.; Carbonnel, F.; Postel-Vinay, S.; Berdelou, A.; Varga, A.; Bahleda, R.; Hollebecque, A.; Massard, C.; Fuerea, A.; Ribrag, V.; Gazzah, A.; Armand, J.P.; Amellal, N.; Angevin, E.; Noel, N.; Boutros, C.; Mateus, C. Journal: European journal of cancer Issue: Volume 54(2016) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. (February 2016) Authors: Michot, J.M.; Bigenwald, C.; Champiat, S.; Collins, M.; Carbonnel, F.; Postel-Vinay, S.; Berdelou, A.; Varga, A.; Bahleda, R.; Hollebecque, A.; Massard, C.; Fuerea, A.; Ribrag, V.; Gazzah, A.; Armand, J.P.; Amellal, N.; Angevin, E.; Noel, N.; Boutros, C.; Mateus, C. Journal: European journal of cancer Issue: Volume 54(2016) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PD-0425: Radiomics for selection of patients treated with immuno-radiotherapy: pooled analysis from 6 studies. (November 2020) Authors: Sun, R.; Sundahl, N.; Hecht, M.; Putz, F.; Lancia, A.; Milic, M.; Carré, A.; Lerousseau, M.; Theo, E.; Battistella, E.; Andres, E. Alvarez; Louvel, G.; Durand-Labrunie, J.; Bockel, S.; Bahleda, R.; Robert, C.; Boutros, C.; Vakalopoulou, M.; Paragios, N.; Frey, B. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-1227: A dose escalation phase 1 study of radiotherapy combined with ipilimumab in metastatic melanoma. (November 2020) Authors: Boutros, C.; Chaput, N.; Lanoy, E.; Larive, A.; Mateus, C.; Routier, E.; Roy, S.; Sun, R.; Lancia, A.; Tao, Y.G.; Ibrahim, N.; Khoury-Abboud, R.; Massard, C.; Bahleda, R.; Schwob, D.; Caramella, C.; Cassard, L.; Soria, J.; Robert, C.; Deutsch, E. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pulmonary nodules and immunotherapy: disease progression or toxicity of anti-PD1/anti-PDL1 checkpoint inhibitors?. (April 2018) Authors: Pradère, P.; Boutros, C.; Scoazec, J.Y.; Dorfmüller, P.; Leroy-Ladurie, F.; Boulate, D.; Le Pavec, J.; Robert, C. Journal: European journal of cancer Issue: Volume 93(2018) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗